Nanoinformatics and biomolecular nanomodeling: a novel move en route for effective cancer treatment

Empowering role of nanoinformatics in design and elucidation of nanoparticles for effective cancer treatment has made this field a fascinating area for researchers, inspiring them to enhance up the quality and efficacy of existing anticancer medicines. Theoretical and computational modeling is being seen as a forefront solution for problems related to surface chemistry, optimized geometry, or other properties in nanoparticle designing and drug delivery. The current review aims to acquaint with the insight story of the incubation of in silico tools and techniques in nanotechnology to develop better anticancer nanomedicines. The review also recapitulates the assets and liabilities of this field and present an outline of existing inventiveness and endeavors of nanoinformatics. We propose how nanoinformatics could hasten up the advancements in anticancer nanomedicines through use of computational tools, nanoparticles repositories & various modeling and simulation methods.

[1]  Nathan A Baker NIH cancer Biomedical Informatics Grid (caBIG®) ICR Nanotechnology Working Group , 2010 .

[2]  M. Kamal,et al.  Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders. , 2014, Current drug metabolism.

[3]  Sergey Shityakov,et al.  In silico models for nanotoxicity evaluation and prediction at the blood-brain barrier level: A mini-review , 2017 .

[4]  Martin Fritts,et al.  Nanoinformatics and DNA-Based Computing: Catalyzing Nanomedicine , 2010, Pediatric Research.

[5]  Mike Holcombe,et al.  Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach , 2015, Scientific Reports.

[6]  Raul E. Cachau,et al.  The Collaboratory for Structural Nanobiology , 2009 .

[7]  Jian Wang,et al.  Nano(Q)SAR: Challenges, pitfalls and perspectives , 2015, Nanotoxicology.

[8]  Iseult Lynch,et al.  Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.

[9]  M. Kamal,et al.  Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier. , 2017, Current drug metabolism.

[10]  Damaris Murry,et al.  The Nanomaterial Registry: facilitating the sharing and analysis of data in the diverse nanomaterial community , 2013, International journal of nanomedicine.

[11]  Jerzy Leszczynski,et al.  CompNanoTox2015: novel perspectives from a European conference on computational nanotoxicology on predictive nanotoxicology , 2017, Nanotoxicology.

[12]  Diana M. Bowman,et al.  Nanotechnology Environmental Health and Safety: Risks, Regulation and Management , 2009 .

[13]  C. Kumar Nanomaterials for cancer therapy , 2006 .

[14]  D. Prakash,et al.  Cancer treatment with nano-diamonds. , 2017, Frontiers in bioscience.

[15]  V Maojo,et al.  Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research. , 2013, Computational science & discovery.

[16]  Mara C. Ebeling,et al.  Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. , 2013, Current drug metabolism.

[17]  Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis , 2011 .

[18]  Pranita P. Kore,et al.  Computer-Aided Drug Design: An Innovative Tool for Modeling , 2012 .

[19]  S. McDougall,et al.  Mathematical modelling of flow through vascular networks: Implications for tumour-induced angiogenesis and chemotherapy strategies , 2002, Bulletin of mathematical biology.

[20]  Indy Hurt,et al.  Nanotoxicology: characterizing the scientific literature, 2000–2007 , 2008, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.

[21]  Yaroslava G. Yingling,et al.  Computational design of an RNA hexagonal nanoring and an RNA nanotube. , 2007, Nano letters.

[22]  Liliana Ironi,et al.  A model-based approach to the assessment of physicochemical properties of drug delivery materials , 2003, Comput. Chem. Eng..

[23]  Mohammad Amjad Kamal,et al.  Recent Advances in Drug Delivery of Polymeric Nano-Micelles. , 2017, Current drug metabolism.

[24]  J. Mesirov,et al.  Automated high-dimensional flow cytometric data analysis , 2009, Proceedings of the National Academy of Sciences.

[25]  Jifu Tan,et al.  Computational Modeling of Nanoparticle Targeted Drug Delivery , 2012 .

[26]  Huajian Gao,et al.  Mechanics of receptor-mediated endocytosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[28]  Mario Grassi,et al.  Mathematical modelling and controlled drug delivery: matrix systems. , 2005, Current drug delivery.

[29]  Martin Fritts,et al.  Nanoinformatics: a new area of research in nanomedicine , 2012, International journal of nanomedicine.

[30]  Mark D. Smucker,et al.  InterNano: e-Science for the Nanomanufacturing Community , 2008, 2008 IEEE Fourth International Conference on eScience.

[31]  Nathan A. Baker,et al.  NanoParticle Ontology for cancer nanotechnology research , 2011, J. Biomed. Informatics.

[32]  Xu Wang,et al.  Application of Nanotechnology in Cancer Therapy and Imaging , 2008, CA: a cancer journal for clinicians.

[33]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[34]  R. Iyengar,et al.  Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. , 2012, Annual review of pharmacology and toxicology.

[35]  Jason A. Papin,et al.  A metabolic network approach for the identification and prioritization of antimicrobial drug targets. , 2012, Trends in microbiology.

[36]  Stephanie A. Morris,et al.  caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine. , 2013, Computational science & discovery.

[37]  J. M Balajee,et al.  COMPUTATIONAL APPROACH FOR PARTICLE SIZE MEASUREMENT OF SILVER NANOPARTICLE FROM ELECTRON MICROSCOPIC IMAGE , 2013 .

[38]  Diane J Burgess,et al.  A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. , 2011, International journal of pharmaceutics.

[39]  Ying Li,et al.  Multiscale modeling and uncertainty quantification in nanoparticle-mediated drug/gene delivery , 2014 .

[40]  Claus-Michael Lehr,et al.  Computational modeling of the sugar-lectin interaction. , 2004, Advanced drug delivery reviews.

[41]  M. Kamal,et al.  Nanotechnology-based inhalation treatments for lung cancer: state of the art , 2015, Nanotechnology, Science and Applications.

[42]  M. Kamal,et al.  Nanotechnology-based approaches in anticancer research , 2012, International journal of nanomedicine.

[43]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[44]  Gregg A. Duncan,et al.  Computational design of nanoparticle drug delivery systems for selective targeting. , 2015, Nanoscale.

[45]  G. Nolan,et al.  Mapping normal and cancer cell signalling networks: towards single-cell proteomics , 2006, Nature Reviews Cancer.

[46]  H. Chung,et al.  Nanomaterials for cancer therapy and imaging , 2011, Molecules and cells.

[47]  James C. Benneyan,et al.  Nanotechnology environmental, health, and safety issues: brief literature review since 2000 , 2009, 2009 IEEE International Symposium on Sustainable Systems and Technology.

[48]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[49]  Laura Hodson,et al.  Nanotechnologies and Nanomaterials in the Occupational Setting , 2010 .

[50]  I. Ali Nano anti-cancer drugs: pros and cons and future perspectives. , 2011, Current cancer drug targets.

[51]  Shuming Nie,et al.  In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots , 2007 .

[52]  V Maojo,et al.  International Efforts in Nanoinformatics Research Applied to Nanomedicine , 2010, Methods of Information in Medicine.

[53]  A. Cuschieri,et al.  Physicochemical properties affecting cellular uptake of carbon nanotubes. , 2010, Nanomedicine.

[54]  Marina A. Dobrovolskaia,et al.  Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[55]  M Murdock,et al.  Quality by design. , 1994, Journal of healthcare materiel management.

[56]  C. López-Alonso,et al.  Informatic resources useful for the development of biomedicalapplications of nanomaterials and their toxicological evaluation. , 2014 .

[57]  Ki-Bum Lee,et al.  Design, synthesis, and characterization of graphene-nanoparticle hybrid materials for bioapplications. , 2015, Chemical reviews.

[58]  A. Voter,et al.  Extending the Time Scale in Atomistic Simulation of Materials Annual Re-views in Materials Research , 2002 .

[59]  Georgia Melagraki,et al.  Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles , 2014 .

[60]  Abdul-Rahim T. Humod,et al.  Fuzzy-Swarm Controller for Automatic Voltage Regulator of Synchronous Generator , 2012 .

[61]  Fernando González-Nilo,et al.  Nanoinformatics: an emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology. , 2011, Biological research.

[62]  Michael L Klein,et al.  Nanoparticle Shape Improves Delivery: Rational Coarse Grain Molecular Dynamics (rcg-md) of Taxol in Worm-like Peg-pcl Micelles 2 , 2022 .

[63]  Mark J. Schulz,et al.  Tiny Medicine: Nanomaterial-Based Biosensors , 2009, Sensors.

[64]  Ian Trase,et al.  Design of Nanoparticle-Based Carriers for Targeted Drug Delivery. , 2016, Journal of nanomaterials.

[65]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[66]  Paul Jen-Hwa Hu,et al.  Theory-Informed Design and Evaluation of an Advanced Search and Knowledge Mapping System in Nanotechnology , 2012, J. Manag. Inf. Syst..

[67]  N. Greig,et al.  Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective. , 2016, Current pharmaceutical design.

[68]  Jennifer L West,et al.  Nanoparticles for thermal cancer therapy. , 2009, Journal of biomechanical engineering.

[69]  Ying Li,et al.  Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles , 2016, Interface Focus.

[70]  K. Nguyen Targeted Nanoparticles for Cancer Therapy: Promises and Challenges , 2011 .

[71]  Yandi Hu,et al.  Synthesis of N/Fe comodified TiO 2 loaded on bentonite for enhanced photocatalytic activity under UV-Vis light , 2016 .

[72]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[73]  S. Kaur,et al.  Nano-Medicine: Promising Drug for Future , 2016 .

[74]  Y. Assaraf,et al.  Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[75]  Y. Tsutsumi,et al.  Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells , 2011, International journal of nanomedicine.

[76]  Hari Singh Nalwa,et al.  Handbook of nanostructured materials and nanotechnology , 2000 .

[77]  Jim E Riviere,et al.  An index for characterization of nanomaterials in biological systems. , 2010, Nature nanotechnology.

[78]  Gerhard Klimeck,et al.  nanoHUB.org: Advancing Education and Research in Nanotechnology , 2008, Computing in Science & Engineering.

[79]  Arezou A Ghazani,et al.  High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. , 2006, Nano letters.

[80]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[81]  V. Yu. Zitserman,et al.  Nanoinformatics: Problems, methods, and technologies , 2016, Scientific and Technical Information Processing.

[82]  Sandra Furlanetto,et al.  Application of quality by design to the development of analytical separation methods , 2012, Analytical and Bioanalytical Chemistry.

[83]  Martin Fritts,et al.  ISA-TAB-Nano: A Specification for Sharing Nanomaterial Research Data in Spreadsheet-based Format , 2013, BMC Biotechnology.

[84]  Ergun Karaagaoglu,et al.  Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach. , 2013, Journal of pharmaceutical sciences.

[85]  Egon L. Willighagen,et al.  eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment , 2015, Journal of Biomedical Semantics.

[86]  B. Berne,et al.  Replica exchange with solute tempering: a method for sampling biological systems in explicit water. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[87]  M. W. van der Kamp,et al.  Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology. , 2013, Biochemistry.

[88]  Stuart Allan,et al.  Nanotechnology in the news , 2006 .

[89]  M. Kamal,et al.  Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics. , 2015, Current drug metabolism.

[90]  Weibo Cai,et al.  Nanoplatforms for targeted molecular imaging in living subjects. , 2007, Small.

[91]  Yu-qiang Ma,et al.  Design strategy of surface decoration for efficient delivery of nanoparticles by computer simulation , 2016, Scientific Reports.

[92]  Jerzy Leszczynski,et al.  Novel approach for efficient predictions properties of large pool of nanomaterials based on limited set of species: nano-read-across , 2015, Nanotechnology.

[93]  Huiquan Wu,et al.  Quality by Design , 2017 .

[94]  Mathieu Lafourcade,et al.  Games with a Purpose (Gwaps): Lafourcade/Games with a Purpose (Gwaps) , 2015 .

[95]  D. Ribatti,et al.  Tumor angiogenesis. From bench to bedside. , 2016, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia.

[96]  Gang Zheng,et al.  Tailoring nanoparticle designs to target cancer based on tumor pathophysiology , 2016, Proceedings of the National Academy of Sciences.

[97]  Pakatip Ruenraroengsak,et al.  Nanosystem drug targeting: Facing up to complex realities. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[98]  Vladimir B Bajic,et al.  In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.

[99]  C. Dass,et al.  Treatment of lung cancer using nanoparticle drug delivery systems. , 2013, Current drug discovery technologies.